Global Retirement Partners, LLC Altimmune, Inc. Transaction History

Global Retirement Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$5.91 - $10.23 $11,820 - $20,460	2,000 Added 2000.0%	2,100 $13,000
Q4 2023 Jan 18, 2024	BUY	$2.14 - $11.62 $214 - $1,162	100 New	100 $1,000
Q3 2021 Oct 22, 2021	SELL	$8.43 - $16.81 $36,771 - $73,325	-4,362 Closed	0 $0
Q1 2021 Apr 14, 2021	BUY	$12.71 - $24.31 $36,376 - $69,575	2,862 Added 190.8%	4,362 $62,000
Q4 2020 Jan 13, 2021	BUY	$7.84 - $14.22 $11,760 - $21,330	1,500 New	1,500 $17,000

190

42.1M

1.05M

582K

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $358M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Global Retirement Partners, LLC with notifications on news.